Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

Condition:   Prostatic Cancer, Castration-Resistant Interventions:   Drug: Darolutamide(Nubeqa, BAY1841788);   Drug: Enzalutamide Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials